Last reviewed · How we verify

NCT04561843

3D Transperineal Ultrasound of the Pelvic Floor Muscles in Women With Pelvic Floor Disorders: A Cross-sectional Study.

Status unknown Last updated 28 September 2020
What this trial tests

trial testing pelvic floor ultrasound in Pelvic Floor Disorders in 91 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
1 December 2021
1 June 2022

Quick facts

Lead sponsorAssiut University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment91
Start date1 December 2020
Primary completion1 December 2021
Estimated completion1 June 2022

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Adults 21 to 50, female only, with Pelvic Floor Disorders. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aimed to evaluate the levator ani muscle in both morphology (rest), and function (contraction and valsalva) in symptomatic women using 2D, 3D trans-perineum ultrasound (TPUS), to compare these features to clinical digital palpation and symptoms, and helping in diagnosis of muscle dysfunction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Floor Disorders

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04561843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing